Drug Shortage Report for ACYCLOVIR SODIUM INJECTION

Last updated on 2021-01-12 History
Report ID 122384
Drug Identification Number 02236926
Brand name ACYCLOVIR SODIUM INJECTION
Common or Proper name Acyclovir Sodium Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ACYCLOVIR
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size Acyclovir Sodium Injection 50 mg/mL SD Vial 20 mL
ATC code J05AB
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2020-08-14
Estimated end date 2020-12-31
Actual end date 2021-01-11
Shortage status Resolved
Updated date 2021-01-12
Company comments Our stock of Acyclovir Sodium Injection 50 mg/mL, 10 mL and 20 mL vials 1/06/21 Fresenius Kabi Canada Ltd. is pleased to advise that our Acyclovir Sodium Injection 50 mg/mL SD Vial 10 mL will be available at Ontario distribution centers today, Tuesday, January 5, 2021 and at all other distribution centers by Friday, January 8, 2021. Our Acyclovir Sodium Injection 50 mg/mL SD Vial 20 mL will also be available at Ontario distribution centers on Monday, January 11, 2021 and at all other distribution centers by Friday, January 15, 2021.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-01-12 English Compare
v4 2021-01-06 French Compare
v3 2021-01-06 English Compare
v2 2020-08-17 French Compare
v1 2020-08-17 English Compare